Specialty pharmacies in spotlight as Valeant ties questioned
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/25/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Outlook Therapeutics (OTLK) halted, news pending
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Valeant Pharma (VRX) Used Backdoor Approach to Gain Pharmacy Stake in California - ProPublica
October 22, 2015 5:48 PM EDTValeant Pharma (NYSE: VRX) is on watch following a new article from ProPublica which highlights documents that raise new questions about the company's pharmacy relationships in California.
From the... More
